Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies

植入式除颤器和老年人:决策和技术模型

基本信息

  • 批准号:
    8858484
  • 负责人:
  • 金额:
    $ 14.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a first submission for an NIA K23 Paul B. Beeson award (RFA-AG-11-009) by Dan D. Matlock, MD, MPH. Dr. Matlock's overarching career goal is to be a leader conducting research that fundamentally changes and improves how older adults make decisions around invasive technologies. His research proposed herein uses Implantable Cardioverter-Defibrillators (ICDs) as a model to study the larger question of how to improve decision making for older adults. Candidate: Dr. Matlock is a board-certified geriatrician and an Assistant Professor of Medicine in the Division of General Internal Medicine at the University of Colorado Denver (UCD). He has completed a Master's in Public Health and has conducted a host of studies focused on regional variations and decision making for ICDs. He works closely with his primary mentor; Dr. Jean Kutner, MD, MPH. He also receives mentorship from his collaborators (including Dr. Fred Masoudi, MD, MSPH) as a member the Colorado Cardiovascular Outcomes Research Group (CCOR), one of the leading cardiovascular outcomes research groups in the country. Training: The proposed K23 career development plan builds on prior experience from fellowship and early career development to focus on three areas that require additional training: 1) Observational data analysis; 2) Qualitative research; and 3) Shared decision making/decision aid development. Accordingly, Dr. Matlock proposes intensive topical mentorship, focused coursework, seminars, and contextual learning through the proposed research. These training activities will enable Dr. Matlock to learn how to best develop decision support interventions tailored to the needs of older adults. Mentors/Environment: Dr. Matlock and his primary mentor, Dr. Kutner have assembled a strong local mentorship team who will guide Dr. Matlock through the proposed training and research activities. To augment this team, Drs. Matlock and Kutner have assembled a panel of national and international advisors with expertise in various aspects of decision making among older adults to monitor Dr. Matlock's progress through the career development program and provide mentorship within their areas of expertise. Additionally, Dr. Matlock is the sole geriatrician in the CCOR making Dr. Matlock the natural lead for projects related to aging. Research: There is a pressing need to challenge the antiquated paternalism that persists in medical decision making in general and decision making for older adults in particular. This study will produce information of direct relevance to those working in clinical practice. Aim 1 will provide real world estimates of the risks and survival for ICD therapy which are essential knowledge to inform decision making. Aim 2 will build upon Dr. Matlock's prior research to answer additional questions about important aspects of ICD decision making for older adults and their family members. A particularly challenging question around ICDs is how to discuss the trade-off between sudden cardiac death versus potentially living longer with progressive heart failure. This study will provide a clear understanding of ICD decision making as it applies to older adults and will lead directly to the development of an ICD decision aid. Aim 3 will use an established framework for decision support and decision aid development guidelines to develop and pilot test a web based ICD decision aid. Summary: Perhaps the biggest innovation of this endeavor is that it is done in collaboration with cardiologists allowing for full understanding of the decision context and maximizing future implementation and dissemination. This collaboration also serves larger goals of spreading geriatric principles into the subspecialties of medicine. Conduct of this mentored research and training proposal, "Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies", will facilitate Dr. Matlock's development into a nationally-recognized independent investigator and leader conducting research that fundamentally changes and improves how older adults make decisions around invasive technologies.
描述(由申请人提供):这是NIA K23 Paul B的首次提交。Beeson奖(RFA-AG-11-009)由Dan D.马特洛克医学博士公共卫生硕士马特洛克的首要职业目标是成为一名领导者,进行从根本上改变和改善老年人如何围绕侵入性技术做出决定的研究。他在本文中提出的研究使用植入式心律转复除颤器(ICD)作为模型,研究如何改善老年人决策的更大问题。候选人:马特洛克博士是一名董事会认证的老年病学家,也是科罗拉多丹佛大学(UCD)普通内科学系的医学助理教授。他已经完成了公共卫生硕士学位,并进行了大量的研究,重点是区域差异和决策的ICD。他与他的主要导师密切合作; Jean Kutner博士,MD,MPH。作为科罗拉多心血管结局研究组(CCOR)的成员,他还接受了他的合作者(包括Fred Masoudi博士,医学博士,MSPH)的指导,该研究组是美国领先的心血管结局研究组之一。培训内容:拟议的K23职业发展计划建立在奖学金和早期职业发展的经验基础上,重点关注三个需要额外培训的领域:1)观察数据分析; 2)定性研究; 3)共同决策/决策辅助发展。因此,马特洛克博士提出了密集的专题辅导,重点课程,研讨会,并通过拟议的研究上下文学习。这些培训活动将使马特洛克博士能够学习如何最好地制定适合老年人需求的决策支持干预措施。导师/环境:马特洛克博士和他的主要导师库特纳博士组建了一个强大的本地导师团队,他们将指导马特洛克博士完成拟议的培训和研究活动。为了加强这个团队,马特洛克和库特纳博士组建了一个由国内和国际顾问组成的小组,他们在老年人决策的各个方面都有专业知识,以监测马特洛克博士通过职业发展计划取得的进展,并在他们的专业领域提供指导。此外,马特洛克博士是CCOR中唯一的老年病学家,这使得马特洛克博士成为与老龄化有关的项目的自然带头人。调研:迫切需要挑战在一般医疗决策,特别是老年人决策中坚持的过时的家长式作风。这项研究将产生与临床实践工作直接相关的信息。目标1将提供ICD治疗的风险和生存率的真实的估计,这是为决策提供信息的基本知识。目标2将以马特洛克博士之前的研究为基础,回答有关老年人及其家庭成员ICD决策重要方面的其他问题。关于ICD的一个特别具有挑战性的问题是如何讨论心源性猝死与进展性心力衰竭的潜在生存时间之间的权衡。这项研究将提供一个清晰的了解ICD的决策,因为它适用于老年人,并将直接导致发展的ICD决策援助。目标3将使用一个既定的决策支持框架和决策辅助开发指南,开发和试点测试基于网络的ICD决策辅助。总结:也许这项奋进的最大创新在于,它是与心脏病专家合作完成的,可以充分了解决策背景,并最大限度地提高未来的实施和传播。这种合作也有助于更大的目标,将老年医学的原则传播到医学的亚专业。这指导研究和培训的建议,“植入式兴奋剂和老年人:决策和技术的模型”,将促进博士马特洛克的发展成为一个国家认可的独立调查员和领导者进行研究,从根本上改变和改善老年人如何围绕侵入性技术作出决定。

项目成果

期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advance directives, advance care planning, and shared decision making: promoting synergy over exclusivity in contemporary context.
预先指示、预先护理计划和共同决策:在当代背景下促进协同而非排他性。
  • DOI:
    10.1016/j.jpainsymman.2013.10.010
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Swetz,KeithM;Matlock,DanielD;Ottenberg,AbigaleL;Mueller,PaulS
  • 通讯作者:
    Mueller,PaulS
Diabetes Mellitus Treatment Deintensification: When Well-Controlled Diabetes Mellitus Becomes Overcontrolled.
糖尿病治疗去强化:当控制良好的糖尿病变得过度控制时。
The experience of fatigue as a distressing symptom of heart failure.
疲劳是心力衰竭的一种令人痛苦的症状。
  • DOI:
    10.1016/j.hrtlng.2012.04.004
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jones,Jacqueline;McDermott,CarrieM;Nowels,CarolynT;Matlock,DanielD;Bekelman,DavidB
  • 通讯作者:
    Bekelman,DavidB
Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey.
锚定目的地治疗左心室辅助装置决策:机械土耳其人调查。
  • DOI:
    10.1016/j.cardfail.2016.04.018
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Paine,ArcadiaM;Allen,LarryA;Thompson,JocelynS;McIlvennan,ColleenK;Jenkins,Amy;Hammes,Andrew;Kroehl,Miranda;Matlock,DanielD
  • 通讯作者:
    Matlock,DanielD
Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy.
纳入患者观点:对植入式心律转复除颤器治疗临床实践指南的严格审查。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel D Matlock其他文献

"Things That You Thought Mattered, None of That Matters": A Qualitative Exploration of Family Caregiver Values following Left Ventricular Assist Device Implantation.
“你认为重要的事情,其实都不重要”:左心室辅助装置植入后家庭护理人员价值观的定性探索。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Avery C. Bechthold;C. McIlvennan;Daniel D Matlock;Deborah B Ejem;Rachel D Wells;Jesse LeJeune;Marie A. Bakitas;J. N. Odom
  • 通讯作者:
    J. N. Odom

Daniel D Matlock的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel D Matlock', 18)}}的其他基金

A Multicenter Trial of a Shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE - ICD Trial
对提供植入式心脏复律除颤器的患者进行共同决策支持干预的多中心试验:DECIDE - ICD 试验
  • 批准号:
    9484150
  • 财政年份:
    2017
  • 资助金额:
    $ 14.31万
  • 项目类别:
A Multicenter Trial of a Shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE - ICD Trial
对提供植入式心脏复律除颤器的患者进行共同决策支持干预的多中心试验:DECIDE - ICD 试验
  • 批准号:
    9890854
  • 财政年份:
    2017
  • 资助金额:
    $ 14.31万
  • 项目类别:
Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies
植入式除颤器和老年人:决策和技术模型
  • 批准号:
    8724298
  • 财政年份:
    2011
  • 资助金额:
    $ 14.31万
  • 项目类别:
Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies
植入式除颤器和老年人:决策和技术模型
  • 批准号:
    8185070
  • 财政年份:
    2011
  • 资助金额:
    $ 14.31万
  • 项目类别:
Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies
植入式除颤器和老年人:决策和技术模型
  • 批准号:
    8520150
  • 财政年份:
    2011
  • 资助金额:
    $ 14.31万
  • 项目类别:
Implanted Defibrillators and Older Adults: A Model of Decisions and Technologies
植入式除颤器和老年人:决策和技术模型
  • 批准号:
    8323883
  • 财政年份:
    2011
  • 资助金额:
    $ 14.31万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 14.31万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了